-
ICH Training
- Training
26 April 2013, Beijing, China
China ICH Study Group workshop on the ICH E11 Guideline
ICH Past Training Events
As part of ICH's strategy on training and capacity-building, the materials from training events are made available on the ICH website in order to expand as broadly as possible the benefits of such training events.25-26 October 2012, Beijing, China
China ICH Study Group workshop on ICH M Guidelines
22-24 October 2012, Beijing, China
DIA ICH endorsed training on E2 Pharmacovigilance Guidelines
22-23 October 2012, Midrand (Johannesburg), South Africa
DIA ICH endorsed training on E2 Pharmacovigilance Guidelines
4-5 October 2011, Seoul, Republic of Korea
APEC AHC workshop on Q8/Q9/Q10 Guidelines
26-27 September 2011, Ottawa, Ontario, Canada
ICH Quality training on Q8/Q9/Q10 Guidelines
27-30 June 2011, Arusha, Tanzania
SADC workshop on the ICH Q7 Guideline
30-31 May 2011, Kuala Lumpur, Malaysia
ASEAN workshop on the ICH Q5C Guideline
25 April 2011, Tokyo, Japan.
ICH Quality training follow up on Q8/Q9/Q10 in Japan
19-20 April 2011, Riyadh, Saudi Arabia
GCC training workshop on ICH Q5A to Q5E Guidelines
2-4 June, 6-8 October and 27-29 October 2010, respectively in Tallinn, Washington DC and Tokyo
ICH Quality IWG training on Q8/Q9/Q10 Guidelines
26-28 July 2010, Kuala Lumpur, Malaysia
ASEAN training on ICH Q8/Q9/Q10 Guidelines
17-19 March 2010, Kuala Lumpur, Malaysia
ASEAN workshop on MedDRA and its Application in Safety Drug Monitoring
2-6 March 2009, Bangkok, Thailand
APEC LSIF/ Thai FDA advanced workshop on Good Clinical Practice (GCP) / Clinical Research Inspection
2-6 February 2009, Bangkok, Thailand
APEC LSIF/ Thai FDA advanced workshop on Review of Drug Development in Clinical Trials
3-5 December 2008, Beijing, China
APEC LSIF/ JCCT on Implementation of ICH Q8/Q9/Q10 and Other Quality Guidelines
27-30 May 2008, Bangkok, Thailand
APEC LSIF/ Thai FDA preliminary workshop on Good Clinical Practice (GCP) / Clinical Research Inspection
17-21 March 2008, Bangkok, Thailand
APEC LSIF/ Thai FDA preliminary workshop on Review of Drug Development in Clinical Trials
12-14 September 2007, Seoul, Korea